You just read:

Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment

News provided by

Bayer HealthCare Pharmaceuticals Inc.

25 Sep, 2015, 19:00 ET